Home/Filings/4/0001415889-25-023707
4//SEC Filing

Elze Christian 4

Accession 0001415889-25-023707

CIK 0001006281other

Filed

Sep 3, 8:00 PM ET

Accepted

Sep 4, 5:00 PM ET

Size

7.7 KB

Accession

0001415889-25-023707

Insider Transaction Report

Form 4
Period: 2025-09-03
Transactions
  • Award

    Stock Options (Right to Buy)

    2025-09-03+15,00015,000 total
    Exercise: $1.64Exp: 2035-09-03Common Stock (15,000 underlying)
  • Award

    Common Stock

    2025-09-03+7,5007,500 total(indirect: By Trust)
Footnotes (3)
  • [F1]Represents restricted shares of common stock awarded to the Reporting Person under the Amended and Restated Protalix BioTherapeutics, Inc. 2006 Stock Incentive Plan, as amended (the "Plan"). The restricted shares vest in 12 equal quarterly installments commencing upon the date of grant.
  • [F2]To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued under the Plan must be registered in the name of a trustee.
  • [F3]The shares of common stock underlying the stock options shall vest in 12 equal quarterly installments commencing upon the date of grant.

Issuer

Protalix BioTherapeutics, Inc.

CIK 0001006281

Entity typeother

Related Parties

1
  • filerCIK 0002075661

Filing Metadata

Form type
4
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 5:00 PM ET
Size
7.7 KB